SecBot SecBot
DEFA14A ·Filed Apr 24, 2026

BBIO

BridgeBio Pharma, Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed6mo ago SEC0001140361-26-016724
Proxy solicitation materials
Actionable Insight • Neutral

Monitor the company's next 10-Q or 10-K filing for any updates on corporate governance or shareholder proposals.

DirectionNeutral
Confidencelow
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$74.52
T+0 close · Apr 24, 2026 · via day close
Latest settled
+10.92%
T+60 · $82.66
Vs SPY
+6.15%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 27 $74.52entry
  2. T+1 · 7mo ago −6.45%α −5.97% · $69.71
  3. T+5 · 7mo ago −7.42%α −7.82% · $68.99
  4. T+20 · 6mo ago −9.11%α −14.07% · $67.73
  5. T+60 · 4mo ago +10.92%α +6.15% · $82.66
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Analysis based on filing metadata only, document content was unavailable

Key Facts

  • Filing type is DEFA14A, indicating a definitive proxy statement.
  • No substantive document content was provided to analyze the vote details, management position, or activist demands.
  • Filing is routine for public companies and typically involves standard corporate governance matters.

Financial Impact

No financial impact data available

Risk Factors

  • Inability to assess potential shareholder activism or governance risks due to missing document content.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001140361-26-016724
Document: 0001140361-26-016724-index-headers.html0001140361-26-016724
Document: 0001140361-26-016724-index.html0001140361-26-016724
Document: 0001140361-26-016724.txt0001140361-26-016724

Track record

38 reports on BBIO

Performance horizon

10 of 13 bullish or bearish reports moved the stock their way by T+20. Best: +26.76% at T+60 after the May 11, 2026 report. 14 of 15 went positive at some point.

Filters
  1. Nov 12, 20264d ago SC 13G/A Neutral 3/10 Entry $78.17 Now $78.30 +0.17% settles Dec 11
  2. Nov 9, 20267d ago Institutional Cluster Bullish 4/10 Entry $77.93 Now $78.30 +0.47% settles Dec 8
  3. Nov 6, 202610d ago Press Release Neutral 2/10 Entry $77.93 Now $78.30 +0.47% settles Dec 8
  4. Oct 29, 202618d ago 8-K Bullish 6/10 No price data
  5. Oct 29, 202618d ago Press Release Bullish 6/10 Entry $74.95 Now $78.30 +4.47% settles Nov 30
  6. Oct 27, 202620d ago SC 13G Neutral 3/10 Entry $70.82 Now $78.30 +10.56% settles Nov 25
  7. Oct 22, 202625d ago Press Release Neutral 1/10 Entry $68.12 Now $78.30 +14.94% settles Nov 19
  8. Oct 13, 20264w ago 8-K Bullish 7/10 Entry $63.30 to $78.67 Now $78.30 +23.70% ▲ +24.28% +27.89% vs SPY
  9. Oct 6, 20265w ago Press Release Bullish 7/10 Entry $66.96 to $74.03 Now $78.30 +16.94% ▲ +10.56% +13.73% vs SPY
  10. Oct 5, 20266w ago Press Release Neutral 2/10 Entry $66.96 to $74.03 Now $78.30 +16.94% ▲ +10.56% +13.73% vs SPY
Showing 10 of 38

US Market Status

Market Closed · Opens Wed (11h 58m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 24, 2026